Skip to main content
$269.44 -$0.68 (-0.3%)

04:00 PM EST on 01/22/21

Biogen Inc (NASDAQ:BIIB)

CAPS Rating: 4 out of 5

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

Current Price $269.44 Mkt Cap $41.5B
Open $270.34 P/E Ratio 8.85
Prev. Close $269.44 Div. (Yield) $0.00 (0.0%)
Daily Range $268.48 - $272.71 Volume 691,169
52-Wk Range $223.25 - $374.99 Avg. Daily Vol. 1,265,115

Caps

How do you think NASDAQ:BIIB will perform against the market?

Add Stock to CAPS Watchlist

All Players

977 Outperform
71 Underperform
 

All-Star Players

215 Outperform
13 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BIIB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

sojournerks (98.29)
Submitted October 27, 2018

Good company in promising sector

JorgeAura (26.21)
Submitted February 02, 2013

Nasdaq in maximums.

Recent Community Commentary

Read the most recent pitches from players about BIIB.

Recs

0
Member Avatar rocker20 (33.51) Submitted: 12/8/2020 8:12:47 AM : Outperform Start Price: $246.30 NASDAQ:BIIB Score: +5.27

strong historical performer with good ROIC

Recs

0
Member Avatar mrbill6 (69.17) Submitted: 11/10/2020 9:47:05 AM : Outperform Start Price: $239.89 NASDAQ:BIIB Score: +3.91

Recent BUY rating

Recs

0
Member Avatar TMFacarchidi (67.17) Submitted: 11/9/2020 4:56:02 PM : Outperform Start Price: $241.67 NASDAQ:BIIB Score: +3.19

Strong portfolio of Alzheimer's disease projects that don't have correlates anywhere else in the market. Demonstrated history of innovating within a difficult space.

Leaderboard

Find the members with the highest scoring picks in BIIB.

Score Leader

optioncoach

optioncoach (93.35) Score: +637.71

The Score Leader is the player with the highest score across all their picks in BIIB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
fwhittlesey 23.31 4/12/2007 Outperform 3Y $43.64 +517.42% +181.61% +335.80 1 Comment
anewday101 89.21 3/5/2007 Outperform 1Y $43.36 +521.40% +194.64% +326.76 0 Comment
tradersinsights 63.36 4/10/2007 Outperform 1Y $44.42 +506.57% +180.12% +326.46 1 Comment
ambina < 20 3/12/2007 Outperform NS $43.95 +513.06% +188.53% +324.53 0 Comment
mtung 35.60 3/8/2007 Outperform NS $44.10 +510.98% +189.16% +321.82 0 Comment
nickysone 61.32 4/9/2007 Outperform 3Y $44.86 +500.62% +179.84% +320.78 1 Comment
mgroeber < 20 4/9/2007 Outperform NS $44.86 +500.62% +179.84% +320.78 0 Comment
apple1jam 72.74 3/6/2007 2/27/2008 Outperform NS $43.94 +513.20% +192.83% +320.37 0 Comment
Actionman2go 62.02 4/13/2007 Outperform 3Y $45.00 +498.76% +179.54% +319.22 1 Comment
gliberty < 20 8/22/2006 Outperform 5Y $42.68 +531.30% +214.45% +316.86 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BIIB.